Advertisement

Pain in Society: Ethical Issues and Public Policy Concerns

  • Ben A. Rich
Chapter

Introduction

This volume appears in the second half of the congressionally declared “Decade of Pain Control and Research” (H.R. 3244, 2000). Such a declaration by the Congress of the United States generates a perception that we are in the midst of a major national public policy initiative promoting the importance of pain relief to the health and well-being of all citizens who are currently or at some time in the future may become the victims of pain. Such a perception would not, however, necessarily comport with reality. Indeed, the very context in which H.R. 3244 arose was the persistent efforts of the opponents of physician-assisted suicide in general, and the Oregon Death With Dignity Act in particular, to enact federal legislation (under the guise of promoting pain relief) that would make it a federal offence for a physician to provide a competent, terminally ill patient who requested it with a lethal prescription, even if state law and public policy supported it. Such a tension...

Keywords

Pain Relief Health Care Professional Pain Management Control Substance Skilled Nursing Facility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Accusation against Eugene B. Whitney, M.D. Medical Board of California Case # 12 2002 133376, Decision December 15, 2004.Google Scholar
  2. American Alliance of Cancer Pain Initiatives (2003). Statement on Intractable Pain Treatment Acts.Google Scholar
  3. Agency for Healthcare Policy and Research (1992). Acute Pain Management. Rockville, MD.Google Scholar
  4. Agency for Healthcare Policy and Research (1994). Management of Cancer Pain. Rockville, MD.Google Scholar
  5. Bergman v. Chin., 2001 No. H205732-1 (Cal App Dept Super Ct 1999).Google Scholar
  6. Cassell, E.J. (1982). The nature of suffering and the goals of medicine. New Eng J Med, 306: 639–645.Google Scholar
  7. Cassell, E.J. (1991). The Nature of Suffering and the Goals of Medicine. New York: Oxford University Press.Google Scholar
  8. Cleeland, C.S., Gonin, R., Hatfield. A.K., Pandya, K.J. (1994). Pain and its treatment in outpatients with metastatic cancer. New Eng J Med, 330: 592–596.CrossRefPubMedGoogle Scholar
  9. Dahl, J.L, Gordon, D.B. (2002). Joint commission pain standards: a progress report. American Pain Society Bulletin, 12: 1,11, 12.Google Scholar
  10. Drug Enforcement Administration. Final Policy on Dispensing Controlled Substances for the Treatment of Pain. (2006) Vol. 71 Fed. Reg. available at wais.access.gps.gov (DOCID: fr06se06-137).Google Scholar
  11. Estate of Henry James v. Hillhaven Corp., No. 89 CVS 64 (N.C. Super. Ct. Jan. 15, 1991).Google Scholar
  12. Federation of State Medical Boards (1998). Model Guidelines for the Use of Controlled Substances for the Treatment of Pain.Google Scholar
  13. Federation of State Medical Boards (2004). Model Policy for the Use of Controlled Substances for the Treatment of Pain Available at http://www.fsmb.org/pdf/2004_grpol_controlled_substances.pdf.
  14. Fishman, S.M., Papazian, J.S., Gonzalez, B.S., Riches, P.S., Gilson, A. (2004). Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain. Pain Medicine, 5: 309–324.CrossRefPubMedGoogle Scholar
  15. Fohr, S.A. (1998). The double effect of pain medication: separating myth from reality. J Palliative Med, 1: 315–328.CrossRefGoogle Scholar
  16. Fox, E. (1997). Predominance of the curative model of medical care – a residual problem. JAMA, 278: 761–763.CrossRefPubMedGoogle Scholar
  17. General Accounting Office. (2002). Prescription Drugs – State Monitoring Programs Provide Useful Tool to Reduce Diversion.Google Scholar
  18. Gilson, A.M, Joranson, D.E. (2001). Controlled substances and pain management: changes in knowledge and attitudes of state medical regulators. Journal Pain Symp Mgmt, 21: 227–237.CrossRefGoogle Scholar
  19. Hill, C.S., Jr., (1995), When will adequate pain treatment be the norm? JAMA, 274: 1870–73Google Scholar
  20. Hill, C.S., Jr. (1996). Government regulatory influences on opioid prescribing and their impact on the treatment of pain of nonmalignant origin. Journal Pain Symp Mgmt, 11: 287–298.CrossRefGoogle Scholar
  21. House Resolution 3244 (2000). Title VI, Sec. 1603. Decade of Pain Control and Research.Google Scholar
  22. In re Paul Bilder, M.D. Oregon Board of Medical Examiners, 1999.Google Scholar
  23. Joint Commission for the Accreditation of Health care Institutions (2007). Comprehensive Accreditation Manual for Hospitals.Google Scholar
  24. Joranson, D.E. (1995). Intractable pain treatment laws and regulations. American Pain Society Bulletin, 5: 1–3, 15–17.Google Scholar
  25. Joranson, D.E. et al. (2002). Pain management and prescription monitoring. Journal Pain Symp Mgmt, 23: 231–238.CrossRefGoogle Scholar
  26. Morgan, J.P. (1985). American opiophobia: customary underutilization of opioid analgesics. Adv Alcohol Subst Abuse, 5: 163–173.PubMedGoogle Scholar
  27. Morris, D.B. (1991). The Culture of Pain. Berkeley: University of California Press.Google Scholar
  28. Musto, D.F. (1999). The American Disease: Origins of Narcotic Control. New York: Oxford University Press.Google Scholar
  29. Pain & Policy Studies Group. University of Wisconsin Comprehensive Cancer Center (2005). State Continuing Medical Education Policies for Pain and Palliative Care.Google Scholar
  30. Pain & Policy Studies Group. University of Wisconsin Comprehensive Cancer Center (2006). States with Prescription Monitoring Programs.Google Scholar
  31. Pellegrino, E.D. (1998). Emerging ethical issues in palliative care. JAMA, 279: 1521–1522.CrossRefPubMedGoogle Scholar
  32. Public Broadcasting System (2001). Thirty Years of America’s Drug War – A Chronology. available at www.pbs.org/wgbh/pages/frontline/shows/drugs/cron.
  33. Rich, B.A. (2000). A prescription for the pain: the emerging standard of care for pain management. William Mitchell L Rev, 26: 1–91.Google Scholar
  34. Rosa Tomlinson, et al. v. Bayberry Care Center, et. al., 2003 Contra Costa County Superior Court, No. C-02-00120.Google Scholar
  35. Taylor, C.L. (2004). Improving referral of patients to hospice through community physician outreach. Journal Pain Symp Mgmt, 28: 294–295.CrossRefGoogle Scholar
  36. United States v. Hurwitz, United States Court of Appeals for the Fourth Circuit, No. 05-4474 (2006).Google Scholar
  37. Von Roenn, J.H, Cleeland, C.S., Gonin, R., Hatfield, A.K., Pandya, K.J. (1993). Physician attitudes and practice in cancer pain management: a survey from the eastern cooperative oncology group. Ann Int Med, 119: 121–126.Google Scholar
  38. Weintraub, M., Satesh, S., Byrne, L., Maharaj, K., Guttmacher, L. (1991). Consequences of the 1989 New York state triplicate benzodiazepine prescription regulations. JAMA, 266: 2392–2397.CrossRefPubMedGoogle Scholar
  39. Weissman, D.E., Haddox, J.D. (1989). Opioid pseudoaddiction. Journal Pain Symp Mgmt, 36: 363–366.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.University of CaliforniaDavis School of MedicineSacramentoUSA

Personalised recommendations